申请人:Hoffman-La Roche Inc.
公开号:US06153605A1
公开(公告)日:2000-11-28
Compounds of formula (I) ##STR1## as defined by the specification. The compounds are useful in the treatment or prevention of vitamin D dependent disorders, particularly psoriasis, basal cell carcinomas, disorders of keratinization and keratosis, leukemia, osteoporosis, hyperparathyroidism accompanying renal failure, transplant rejection and graft vs. host disease.
化合物的化学式为(I) ##STR1##,如规范所定义。这些化合物在治疗或预防维生素D依赖性疾病方面很有用,特别是对于银屑病、基底细胞癌、角化和角化症、白血病、骨质疏松症、伴随肾功能衰竭的甲状旁腺功能亢进、移植排斥和移植物抗宿主病等疾病。